Zhang Linda, Chang Raymond Chuen-Chung, Chu Leung-Wing, Mak Henry Ka-Fung
Department of Diagnostic Radiology, The University of Hong Kong HKSAR.
Am J Nucl Med Mol Imaging. 2012;2(3):386-404. Epub 2012 Jul 10.
With Alzheimer's disease (AD) quickly becoming the most costly disease to society, and with no disease-modifying treatment currently, prevention and early detection have become key points in AD research. Important features within this research focus on understanding disease pathology, as well as finding biomarkers that can act as early indicators and trackers of disease progression or potential treatment. With the advances in neuroimaging technology and the development of new imaging techniques, the search for cheap, noninvasive, sensitive biomarkers becomes more accessible. Modern neuroimaging techniques are able to cover most aspects of disease pathology, including visualization of senile plaques and neurofibrillary tangles, cortical atrophy, neuronal loss, vascular damage, and changes in brain biochemistry. These methods can provide complementary information, resulting in an overall picture of AD. Additionally, applying neuroimaging to animal models of AD could bring about greater understanding in disease etiology and experimental treatments whilst remaining in vivo. In this review, we present the current neuroimaging techniques used in AD research in both their human and animal applications, and discuss how this fits in to the overall goal of understanding AD.
随着阿尔茨海默病(AD)迅速成为对社会成本最高的疾病,且目前尚无疾病修饰治疗方法,预防和早期检测已成为AD研究的重点。该研究的重要特征集中在理解疾病病理学,以及寻找可作为疾病进展或潜在治疗的早期指标和追踪器的生物标志物。随着神经成像技术的进步和新成像技术的发展,寻找廉价、无创、敏感的生物标志物变得更加可行。现代神经成像技术能够涵盖疾病病理学的大多数方面,包括老年斑和神经原纤维缠结的可视化、皮质萎缩、神经元丢失、血管损伤以及脑生化变化。这些方法可以提供互补信息,从而形成AD的整体图景。此外,将神经成像应用于AD动物模型可以在保持体内状态的同时,增进对疾病病因和实验性治疗的理解。在本综述中,我们介绍了目前在AD研究中用于人类和动物的神经成像技术,并讨论了这如何契合理解AD的总体目标。